Skip to content

Clinical trials

Renal Insufficiency, Chronic trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Phase: Not applicable Country / region: United States Clear all

309 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20066
20075
200811
200912
20109
201110
201211
201310
201415
201511
201616
201725
201816
201915
202018
202117
202214
202318
202420
202525
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed185
Recruiting42
Terminated26
Active, not recruiting15
Unknown status15
Not yet recruiting10
Withdrawn9
Enrolling by invitation7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duke University15
University of California, San Francisco11
VA Office of Research and Development10
Brigham and Women's Hospital9
University of Pennsylvania9
University of Colorado, Denver8
NYU Langone Health7
Johns Hopkins University6
Massachusetts General Hospital6
University of Michigan6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic309
Kidney Failure, Chronic48
Hypertension47
Diabetes Mellitus28
Kidney Diseases18
Cardiovascular Diseases17
Heart Failure17
Diabetes Mellitus, Type 215
Renal Insufficiency10
Albuminuria8

Trials

Showing 1 to 25 of 309. Each trial links to its page on Pharma Observatory.

209 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.